Banco Bilbao Vizcaya Argentaria, S.A. Regeneron Pharmaceuticals, Inc. Transaction History

Banco Bilbao Vizcaya Argentaria, S.A.

$9.35 Billion
Q4 2024

A detailed history of Banco Bilbao Vizcaya Argentaria, S.A. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Banco Bilbao Vizcaya Argentaria, S.A. holds 37,519 shares of REGN stock, worth $26.8 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

37,519

Previous 37,698 0.47%

Holding current value

$26.8 Million

Previous $39.6 Million 32.56%

% of portfolio

0.29%

Previous 0.46%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$701.85 - $1046.91 $125,631 - $187,396	-179 Reduced 0.47%	37,519 $26.7 Million
Q3 2024 Nov 12, 2024	BUY	$1024.09 - $1201.76 $38.6 Million - $45.3 Million	37,698 New	37,698 $39.6 Million
Q2 2024 Aug 06, 2024	BUY	$883.2 - $1071.19 $839,040 - $1.02 Million	950 Added 2.34%	41,598 $43.7 Million
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $476,620 - $524,488	528 Added 1.32%	40,648 $39.1 Million
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $433,325 - $492,870	-559 Reduced 1.37%	40,120 $35.2 Million
Q3 2023 Nov 08, 2023	SELL	$692.45 - $844.37 $558,114 - $680,562	-806 Reduced 1.94%	40,679 $33.5 Million
Q2 2023 Aug 04, 2023	BUY	$700.03 - $830.35 $1.03 Million - $1.22 Million	1,472 Added 3.68%	41,485 $29.8 Million
Q1 2023 May 09, 2023	SELL	$680.49 - $826.97 $370,186 - $449,871	-544 Reduced 1.34%	40,013 $32.9 Million
Q4 2022 Feb 13, 2023	BUY	$705.89 - $766.39 $686,830 - $745,697	973 Added 2.46%	40,557 $29.3 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $2.28 Million - $2.87 Million	-3,965 Reduced 9.1%	39,584 $27.2 Million
Q2 2022 Aug 08, 2022	BUY	$548.35 - $738.84 $6.07 Million - $8.18 Million	11,078 Added 34.12%	43,549 $25.7 Million
Q1 2022 May 12, 2022	BUY	$595.12 - $698.43 $1.74 Million - $2.04 Million	2,925 Added 9.9%	32,471 $22.8 Million
Q4 2021 Feb 15, 2022	BUY	$543.48 - $670.97 $10.6 Million - $13.1 Million	19,497 Added 194.02%	29,546 $18.9 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $1.74 Million - $2.06 Million	3,030 Added 43.17%	10,049 $6.1 Million
Q2 2021 Aug 06, 2021	BUY	$472.8 - $558.54 $1.99 Million - $2.35 Million	4,206 Added 149.52%	7,019 $3.75 Million
Q1 2021 May 13, 2021	SELL	$446.73 - $548.2 $876,930 - $1.08 Million	-1,963 Reduced 41.1%	2,813 $1.33 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $260,195 - $330,741	544 Added 12.85%	4,776 $2.31 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $216,810 - $261,967	398 Added 10.38%	4,232 $2.37 Million
Q2 2020 Aug 12, 2020	BUY	$493.32 - $643.92 $1.42 Million - $1.86 Million	2,881 Added 302.31%	3,834 $2.39 Million
Q1 2020 May 13, 2020	BUY	$336.18 - $494.43 $26,222 - $38,565	78 Added 8.91%	953 $465,000
Q4 2019 Feb 13, 2020	BUY	$274.13 - $376.51 $239,863 - $329,446	875 New	875 $328,000

Others Institutions Holding REGN

# of Institutions

1,487

Shares Held

85.7M

Call Options Held

1.53M

Put Options Held

1.43M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.5B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.

Account

Banco Bilbao Vizcaya Argentaria, S.A. Regeneron Pharmaceuticals, Inc. Transaction History